R89Q (p.Arg89Gln) variant of IRS1 (Insulin receptor substrate 1)
R89Q (p.Arg89Gln) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
R89Q (p.Arg89Gln) variant details
- p.Arg89Gln
- NCI-TCGA Cosmic COSV5933
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.